Xu, J., Fu, L., Bai, J., Zhong, H., Kuang, Z., Zhou, C., . . . Pan, Z. (2021). Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways. Stem Cell Res Ther.
Styl cytowania ChicagoXu, Jianxiang, et al. "Low-dose IL-34 Has No Effect On Osteoclastogenesis but Promotes Osteogenesis of HBMSCs Partly Via Activation of the PI3K/AKT and ERK Signaling Pathways." Stem Cell Res Ther 2021.
Styl cytowania MLAXu, Jianxiang, et al. "Low-dose IL-34 Has No Effect On Osteoclastogenesis but Promotes Osteogenesis of HBMSCs Partly Via Activation of the PI3K/AKT and ERK Signaling Pathways." Stem Cell Res Ther 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..